Sickle Cell Disease Treatment Market size | 2021 Global Industry Forecast To 2026, is latest report on Global Sickle Cell Disease Treatment Industry, published by Fortune Business Insights. Report provides comprehensive information on Global Sickle Cell Disease Treatment Market and Impact of Covid-19 on Healthcare Industry. According to report Global market value of Sickle Cell Disease Treatment is to hit USD 1.44 billion value by 2020 at CAGR of 18.5%. Report segments Sickle Cell Disease Treatment Market By Treatment Modality (Bone Marrow Transplant, Blood Transfusion, Pharmacotherapy (Hydroxyurea and Branded Drugs (Endari, Adakveo, Oxbryta, Zynteglo, CTX001, Mitapivat, and FT-4202))), By End User (Hospitals, Specialty Clinics, and Others), and Regional Forecast, 2020-2027
Major Sickle Cell Disease Treatment manufacturers are studied in this report for better understanding of global market scenario:
- Novartis AG
- Global Blood Therapeutics Inc.
- Emmaus Medical Inc.
- Addmedica
- Medunik USA Inc.
- Bristol-Myers Squibb Company
Get Sample Report Brochure Of Sickle Cell Disease Treatment Market at:
The global sickle cell disease treatment market size is expected to reach USD 7.71 billion in 2027, exhibiting a CAGR of 18.5% during the forecast period. The unmet needs of patients and lack of novel therapies has resulted in research grants from governments, which, in turn, will promote the growth of the market, states Fortune Business Insights, in a report, titled “Sickle Cell Disease Treatment Market Size, Share & Industry Analysis, By Treatment Modality (Bone Marrow Transplant, Blood Transfusion, Pharmacotherapy (Hydroxyurea and Branded Drugs (Endari, Adakveo, Oxbryta, Zynteglo, CTX001, Mitapivat, and FT-4202))), By End User (Hospitals, Specialty Clinics, and Others), and Regional Forecast, 2020-2027.” The market size stood at USD 1.35 billion in 2019.
The entire world is fighting with the COVID-19 pandemic, which has severely disrupted trades across the globe. The authorities of several countries have initiated lockdown to prevent the spread of this deadly virus. Such plans have caused disturbances in the production and supply chain. But, with time and resolution, we will be able to combat this stern time and get back to normality. Our well-revised reports will help companies receive in-depth information about every market’s present scenario so that you can adopt the necessary strategies accordingly.
The sickle cell disease treatment market highpoints a comprehensive study of the market. It also offers essential facts about prominent players, besides revealing data about central regions in the market. The report includes key drivers and trends prevailing in the industry. Significant development, along with COVID’s impact, is covered in the study.
Growing Popularity of Electric Vehicles Worldwide to Restrict the Market
The introduction of innovative drugs and therapies to treat sickle cell diseases can spur lucrative opportunities for the market. For instance, in 2017, FDA approved Emmaus Life Sciences product Endari to treat patients with sickle cell disease aged five years and older. Moreover, the approval of three products by the regulatory bodies such as the FDA and EMA will foster the market’s healthy growth. For instance, Oxbryta (Global Blood Therapeutics), Adakveo (Novartis AG), and Endari (Emmaus Life Sciences) are being utilized in the treatment of the disease. Oxbryta has been approved ahead of its statutory deadline. Moreover, products such as Zynteglo, CTX001, Mitapivat, and FT-4202 are expected to receive approval in the forthcoming years, which, in turn, will enable speedy expansion of the market. For instance, CTX001 has been granted EMA’s priority medicines (PRIME) designation in Europe.
The global pandemic, COVID-19, has led to severe repercussion owing to its widespread effects across several economies. Several industries are facing unprecedented losses owing to the lockdown announced by several governments across the globe that has resulted in the complete shutdown of the businesses. The crippling economy, however, is being revived through collective efforts from the government as well as the industries and is expected to bounce back in the coming years.
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing. The financial parameters which are assessed include the sales, profits and the overall revenue generated by the key players of Market. Furthermore, the report offers a detailed analysis and information as per Sickle Cell Disease Treatment Market Growth Analysis by manufacturers, market segments helping our readers to get a comprehensive overview of the global market. Several players are planning to focus on developing cost-effective products or services, aiming to maintain a strong foothold in the market.
Sickle Cell Disease Treatment Market report examines competitive scenario by analyzing key players in the market. The company profiling of leading market players is included this report with Porter’s five forces analysis and Value Chain analysis. Further, the strategies exercised by the companies for expansion of business through mergers, acquisitions, and other business development measures are discussed in the report. The financial parameters which are assessed include the sales, profits and the overall revenue generated by the key players of Market.
Speak to Sickle Cell Disease Treatment Industry Analyst:
Competitive And Regional Analysis:
This report focuses on Sickle Cell Disease Treatment Market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. Regional analysis is another highly comprehensive part of the research and analysis study of the global market presented in the report.
North America to Hold Lion’s Share in the Market; Asia-Pacific to Follow
The U.S market size stood at USD 0.71 billion in 2019 and is expected to remain dominant during the forecast period. The growth in the region is attributed to improving access to SCD treatment and potential pipeline candidates. The strong government support in the U.S. will further foster the healthy development of the market. According to the Center for International Blood and Marrow Transplant Research, in 2017, 157 hematopoietic cell transplants were performed in 2017 in the U.S for SCD. The number of BMT increased by 35.3% during 2013-2017. These factors together are expected to favor growth in the region.
Delay in non-urgent surgeries has resulted in a major drop in the number of BMT and blood transfusion procedures. The pandemic severely affected the demand and blood donor base. Moreover, lockdown and travel restrictions have led to a decline in the number of donors and the cancellation of numerous blood drives worldwide. For instance, U.S. blood centers witnessed a 30% decline in blood drives scheduled for the rest of the year, leading to about 250,000 missed donations. Furthermore, according to American Red Cross Blood Services, more than 50,000 blood drives have been canceled or moved due to the pandemic. These aforementioned factors reveal the enormous loss encountered by the sickle cell disease treatment industry during the coronavirus.
Sickle Cell Disease Treatment Highlights of the Report:
- Market Penetration: Comprehensive information on the product portfolios of the top players in the Supply Chain Analytics market.
- Product Development/Innovation: Detailed insights on the upcoming technologies, RandD activities, and product launches in the market
- Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments of the leading players in the market
- Market Development: Comprehensive information about emerging markets. This report analyzes the market for various segments across geographies
- Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the Supply Chain Analytics market
Browse complete report information at:
https://www.fortunebusinessinsights.com/industry-reports/sickle-cell-disease-treatment-market-101009
Key questions answered in the report:
- What are the opportunities & challenges for new entrants?
- Who are the prominent vendors present in the global market?
- Which segment would provide the most opportunity for market growth?
- Where will the current developments take the industry in the long term?
Table of Content:
1 Sickle Cell Disease Treatment Market Overview
1.1 Sickle Cell Disease Treatment Product Overview
1.2 Sickle Cell Disease Treatment Market Segment by Type
1.3 Global Sickle Cell Disease Treatment Market Size by Type (2015-2026)
1.3.1 Sickle Cell Disease Treatment Global Market Size Overview by Type (2015-2026)
1.3.2 Global Sickle Cell Disease Treatment Historic Market Size Review by Type (2015-2021)
1.3.2.1 Sickle Cell Disease Treatment Sales Global Market Share Breakdown by Type (2015-2026)
1.3.2.2 Sickle Cell Disease Treatment Global Market Share Breakdown by Type (2015-2026)
1.3.2.3 Global Sickle Cell Disease Treatment Average Selling Price (ASP) by Type (2015-2026)
1.3.3 Sickle Cell Disease Treatment Market Size Forecast by Type (2021-2026)
1.3.3.1 Global Sickle Cell Disease Treatment Sales Market Share Breakdown by Application (2021-2026)
1.3.3.2 Global Sickle Cell Disease Treatment Revenue Market Share Breakdown by Application (2021-2026)
1.3.3.3 Global Sickle Cell Disease Treatment Average Selling Price (ASP) by Application (2021-2026)
1.4 Key Regions Market Size Segment by Type (2015-2021)
1.4.1 North America Sickle Cell Disease Treatment Sales Breakdown by Type (2015-2026)
1.4.2 Europe Sickle Cell Disease Treatment Sales Breakdown by Type (2015-2026)
1.4.3 Asia-Pacific Sickle Cell Disease Treatment Sales Breakdown by Type (2015-2026)
1.4.4 Latin America Sickle Cell Disease Treatment Sales Breakdown by Type (2015-2026)
1.4.5 Middle East and Africa Sickle Cell Disease Treatment Sales Breakdown by Type (2015-2026)
2 Global Sickle Cell Disease Treatment Market Competition by Company
2.1 Global Top Players by Sickle Cell Disease Treatment Sales (2015-2021)
2.2 Global Top Players by Sickle Cell Disease Treatment Revenue (2015-2021)
2.3 Global Top Players Sickle Cell Disease Treatment Average Selling Price (ASP) (2015-2021)
2.4 Global Top Company Sickle Cell Disease Treatment Manufacturing Base Distribution, Sales Area, Product Type
2.5 Sickle Cell Disease Treatment Market Competitive Situation and Trends
2.5.1 Sickle Cell Disease Treatment Market Growth Rate (2015-2021)
2.5.2 Global 5 and 10 Largest Company by Sickle Cell Disease Treatment Sales and Revenue in 2019
2.6 Global Sickle Cell Disease Treatment Top Company by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Sickle Cell Disease Treatment as of 2019)
2.7 Date of Key Company Enter into Sickle Cell Disease Treatment Market
2.8 Key Company Sickle Cell Disease Treatment Product Offered
2.9 Mergers and Acquisitions, Expansion
3 Global Sickle Cell Disease Treatment Status and Outlook by Region (2015-2026)
3.1 Global Sickle Cell Disease Treatment Market Size and CAGR by Region: 2015 VS 2021 VS 2026
3.2 Global Sickle Cell Disease Treatment Market Size Market Share by Region (2015-2021)
3.2.1 Global Sickle Cell Disease Treatment Sales Market Share by Region (2015-2021)
3.2.2 Global Sickle Cell Disease Treatment Revenue Market Share by Region (2015-2021)
3.2.3 Global Sickle Cell Disease Treatment Sales, Revenue, Price and Gross Margin (2015-2021)
3.3 Global Sickle Cell Disease Treatment Market Size Market Share by Region (2021-2026)
3.3.1 Global Sickle Cell Disease Treatment Sales Market Share by Region (2021-2026)
3.3.2 Global Sickle Cell Disease Treatment Revenue Market Share by Region (2021-2026)
3.3.3 Global Sickle Cell Disease Treatment Sales, Revenue, Price and Gross Margin (2021-2026)
3.4 North America Sickle Cell Disease Treatment Market Size By Growth (2015-2026)
3.4.1 North America Sickle Cell Disease Treatment Revenue By Growth (2015-2026)
3.4.2 North America Sickle Cell Disease Treatment Sales By Growth (2015-2026)
3.5 Asia-Pacific Sickle Cell Disease Treatment Market Size By Growth (2015-2026)
3.5.1 Asia-Pacific Sickle Cell Disease Treatment Revenue By Growth (2015-2026)
3.5.2 Asia-Pacific Sickle Cell Disease Treatment Sales By Growth (2015-2026)
3.6 Europe Sickle Cell Disease Treatment Market Size By Growth (2015-2026)
3.6.1 Europe Sickle Cell Disease Treatment Revenue By Growth (2015-2026)
3.6.2 Europe Sickle Cell Disease Treatment Sales By Growth (2015-2026)
3.7 Latin America Sickle Cell Disease Treatment Market Size By Growth (2015-2026)
3.7.1 Latin America Sickle Cell Disease Treatment Revenue By Growth (2015-2026)
3.7.2 Latin America Sickle Cell Disease Treatment Sales By Growth (2015-2026)
3.8 Middle East and Africa Sickle Cell Disease Treatment Market Size By Growth (2015-2026)
3.8.1 Middle East and Africa Sickle Cell Disease Treatment Revenue By Growth (2015-2026)
3.8.2 Middle East and Africa Sickle Cell Disease Treatment Sales By Growth (2015-2026)
4 Global Sickle Cell Disease Treatment by Application
4.1 Sickle Cell Disease Treatment Segment by Application
4.1.1 Residential
4.1.2 Commercial
4.2 Global Sickle Cell Disease Treatment Sales by Application: 2015 VS 2021 VS 2026
4.3 Global Sickle Cell Disease Treatment Historic Sales by Application (2015-2021)
4.4 Global Sickle Cell Disease Treatment Forecasted Sales by Application (2021-2026)
4.5 Key Regions Sickle Cell Disease Treatment Market Size by Application
4.5.1 North America Sickle Cell Disease Treatment by Application
4.5.2 Europe Sickle Cell Disease Treatment by Application
4.5.3 Asia-Pacific Sickle Cell Disease Treatment by Application
4.5.4 Latin America Sickle Cell Disease Treatment by Application
4.5.5 Middle East and Africa Sickle Cell Disease Treatment by Application
5 North America Sickle Cell Disease Treatment Market Size by Country (2015-2026)
5.1 North America Market Size Market Share by Country (2015-2021)
5.1.1 North America Sickle Cell Disease Treatment Sales Market Share by Country (2015-2021)
5.1.2 North America Sickle Cell Disease Treatment Revenue Market Share by Country (2015-2021)
5.2 North America Market Size Market Share by Country (2021-2026)
5.2.1 North America Sickle Cell Disease Treatment Sales Market Share by Country (2021-2026)
5.2.2 North America Sickle Cell Disease Treatment Revenue Market Share by Country (2021-2026)
5.3 North America Market Size By Growth by Country
5.3.1 U.S. Sickle Cell Disease Treatment Market Size By Growth (2015-2026)
5.3.2 Canada Sickle Cell Disease Treatment Market Size By Growth (2015-2026)
About Us:
Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.
At Fortune Business Insights™, we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.
Contact Us:
Fortune Business Insights Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune -411045, Maharashtra, India.
US: +1 424 253 0390
UK: +44 2071 939123
APAC: +91 744 740 1245